-transparent.png){kind=logo}
In response to arginine infusion, Zucker fatty rats developed hyperglycemia accompanying hyperglucagonemia and hyperinsulinemia. The hyperglycemia could not be explained by changes in the ratio of glucagon/insulin. However, arginine infusion failed to increase plasma glucose in fatty rats pretreated with anti-glucagon serum, suggesting a hyperglycemic effect of glucagon released by arginine. Kinetic studies of glucose metabolism revealed that the rates of glucose appearance (Ra) and glucose disappearance (Rd) of lean rats rapidly and simultaneously increased to the same extent after the start of arginine infusion. By contrast, in fatty rats, Ra markedly increased immediately after the start of the infusion, but Rd did not significantly increase until hyperglycemia was established. Overall insulin sensitivity of fatty rats was markedly reduced, determined by the steady state plasma glucose method. We conclude tht arginine-induced hyperglycemia in fatty rats is caused by enhanced glucose output from the liver due to hyperglucagonemia and/or by decreased glucose utilization due to insulin resistance.
K Nishikawa, and
H Ikeda, and
T Matsuo
July 2002,
Cardiovascular research,
K Nishikawa, and
H Ikeda, and
T Matsuo
February 1979,
Metabolism: clinical and experimental,
K Nishikawa, and
H Ikeda, and
T Matsuo
February 1988,
Endocrinology,
K Nishikawa, and
H Ikeda, and
T Matsuo
January 1963,
Prace. Lodzkie Towarzystwo Naukowe. Wydzial IV, Nauk Lekarskich,
K Nishikawa, and
H Ikeda, and
T Matsuo
August 2015,
Biochemical pharmacology,
K Nishikawa, and
H Ikeda, and
T Matsuo
June 1988,
Molecular and cellular biochemistry,
K Nishikawa, and
H Ikeda, and
T Matsuo
May 1956,
The Journal of clinical investigation,
K Nishikawa, and
H Ikeda, and
T Matsuo
January 1971,
Archiv fur Kreislaufforschung,
K Nishikawa, and
H Ikeda, and
T Matsuo
November 1988,
Atherosclerosis,
K Nishikawa, and
H Ikeda, and
T Matsuo
January 1952,
Medicina,
